All In Biotech

Drugs by condition

Drugs approved for bipolar disorder

Brand-name prescription drugs and biologics whose FDA label lists bipolar disorder as an approved use. Matched on the label phrases: "bipolar".

Last checked: Nov 19, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations

Brand-name drugs approved

34

Still marketed, NDA or BLA

Drug classes

5

Novel drugs

13

New molecular entities and new biologics

In development

13

Investigational drugs in Phase 2 or 3

Newest approvals

The most recently first-approved brand-name drugs for bipolar disorder.

  • Bysanti (Milsaperidone) · Vanda Pharms INC NovelFeb 20, 2026
  • Subvenite (Lamotrigine) · Owp Pharms Sep 16, 2025
  • Uzedy (Risperidone) · Teva Apr 28, 2023
  • Abilify Asimtufii (Aripiprazole) · Otsuka Apr 27, 2023
  • Rykindo (Risperidone) · Shandong Luye Jan 13, 2023

All approved drugs for bipolar disorder, by class

Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 194 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.

Atypical Antipsychotic (14)

  • Lybalvi Olanzapine, Samidorphan L-Malate · Alkermes INC · 2021
  • Caplyta Lumateperone Tosylate · Intra-Cellular · 2019
  • Vraylar Cariprazine Hydrochloride · Abbvie · 2015
  • Fanapt Iloperidone · Vanda Pharms INC · 2009
  • Abilify Aripiprazole · Otsuka · 2002
  • Geodon Ziprasidone Hydrochloride · Viatris · 2001
  • Zyprexa Olanzapine · Cheplapharm · 1996
  • Risperdal Risperidone · Janssen Pharms · 1993
  • Uzedy Risperidone · Teva · 2023
  • Abilify Asimtufii Aripiprazole · Otsuka · 2023
  • Zyprexa Olanzapine · Cheplapharm · 2004
  • Geodon Ziprasidone Mesylate · Viatris · 2002
  • Zyprexa Zydis Olanzapine · Cheplapharm · 2000
  • Risperdal Risperidone · Janssen Pharms · 1996

Anti-epileptic Agent (4)

  • Lamictal Lamotrigine · Glaxosmithkline LLC · 1994
  • Subvenite Lamotrigine · Owp Pharms · 2025
  • Lamictal Odt Lamotrigine · Glaxosmithkline LLC · 2009
  • Lamictal Cd Lamotrigine · Glaxosmithkline LLC · 1998

Central alpha-2 Adrenergic Agonist (1)

  • Igalmi Dexmedetomidine Hydrochloride · Teva · 2022

Mood Stabilizer (1)

  • Equetro Carbamazepine · Validus Pharms · 2004

Class not listed in FDA's data (14)

Drugs in development for bipolar disorder

Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.

Search the pipeline
  • BrenipatideLY3537031Phase 313 trials

    Eli Lilly · Alcohol Use Disorder, Irritable Bowel Syndrome, Depressive Disorder, Major

  • AzetukalnerXEN1101Phase 39 trials

    Xenon Pharmaceuticals Inc. · Focal Onset Seizures, Major Depressive Disorder, Bipolar Disorder

  • BHV-7000Phase 36 trials

    Biohaven Therapeutics Ltd. · Focal Epilepsy, Major Depressive Disorder, Bipolar Disorder

  • NBI-1117568Phase 35 trials

    Neurocrine Biosciences · Schizophrenia, Bipolar I Disorder, Mania

  • RAP-219Phase 35 trials

    Rapport Therapeutics Inc. · Focal Epilepsy, Epilepsy, Focal Seizure

  • CYM-53093Navacaprant, NMRA-335140Phase 34 trials

    Neumora Therapeutics, Inc. · Major Depressive Disorder, Major Depressive Episode Associated With Bipolar II Disorder

  • LB-102Phase 34 trials

    LB Pharmaceuticals Inc. · Schizophrenia, Bipolar I Disorder

  • OLZSAM, ALKS 3831Phase 32 trials

    Alkermes, Inc. · Bipolar I Disorder, Schizophrenia

  • ABBV-932Phase 23 trials

    AbbVie · Bipolar I or II Disorder, Generalized Anxiety Disorder (GAD), Bipolar I Disorder

  • AL-001lithium salicylate, L-proline cocrystalPhase 23 trials

    Beijing Anlong Biopharmaceutical Co., Ltd. · Wet Age-related Macular Degeneration (wAMD), Bipolar I Disorder

  • ABX-002Phase 22 trials

    Autobahn Therapeutics, Inc. · Major Depressive Disorder, Bipolar Disorder Depression

  • IcalcaprantABBV-1354, CVL-354Phase 22 trials

    AbbVie · Bipolar I Disorder, Bipolar II Disorder, Major Depressive Disorder

  • ALTO-100Phase 21 trial

    Alto Neuroscience · Bipolar Disorder I or II With a Major Depressive Episode

2 discontinued brand-name drugs whose label still names it

More on bipolar disorder: recruiting trials · published research

Related in psychiatry: Depression (major depressive disorder) · Schizophrenia · ADHD · Anxiety disorders · Insomnia · Opioid use disorder · Alcohol dependence · Smoking cessation · PTSD · Postpartum depression

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.